Jerel Davis - 29 Dec 2022 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Reporting relationship: Director
Issuer ticker: RPTX
Reported as of: 29 Dec 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Jan 2023, 15:38:20 UTC
Prior SEC filing: 27 Dec 2022
Next SEC filing: 03 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ Max Eisenberg, Attorney-in-Fact for Jerel C. Davis

Key filing fact

Jerel Davis filed Form 4 for Repare Therapeutics Inc. (RPTX) on 03 Jan 2023.

Key facts

This page summarizes Jerel Davis's Form 4 filing for Repare Therapeutics Inc. (RPTX).
12 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 03 Jan 2023, 15:38.

Change

Previous filing in this sequence was filed on 27 Dec 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RPTX transaction

Common Shares

Other

Transaction value: $0
Shares: -287,157
Change %: -34%
Price: $0.000000
Shares after: 563,403
Date: 29 Dec 2022
Ownership: See Footnote
Footnotes: F1, F2

RPTX transaction

Common Shares

Other

Transaction value: $0
Shares: +62,026
Change %
Price: $0.000000
Shares after: 62,026
Date: 29 Dec 2022
Ownership: See Footnote
Footnotes: F3, F4

RPTX transaction

Common Shares

Other

Transaction value: $0
Shares: -8,638
Change %: -34%
Price: $0.000000
Shares after: 16,949
Date: 29 Dec 2022
Ownership: See Footnote
Footnotes: F5, F6

RPTX transaction

Common Shares

Other

Transaction value: $0
Shares: +1,866
Change %: +3%
Price: $0.000000
Shares after: 63,892
Date: 29 Dec 2022
Ownership: See Footnote
Footnotes: F4, F7

RPTX transaction

Common Shares

Other

Transaction value: $0
Shares: -9,561
Change %: -34%
Price: $0.000000
Shares after: 18,761
Date: 29 Dec 2022
Ownership: See Footnote
Footnotes: F8, F9

RPTX transaction

Common Shares

Other

Transaction value: $0
Shares: +2,065
Change %: +3.2%
Price: $0.000000
Shares after: 65,957
Date: 29 Dec 2022
Ownership: See Footnote
Footnotes: F4, F10

RPTX transaction

Common Shares

Other

Transaction value: $0
Shares: -65,957
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 29 Dec 2022
Ownership: See Footnote
Footnotes: F4, F11

RPTX transaction

Common Shares

Other

Transaction value: $0
Shares: +1,240
Change %: +5.9%
Price: $0.000000
Shares after: 22,117
Date: 29 Dec 2022
Ownership: Direct
Footnotes: F12

RPTX transaction

Common Shares

Other

Transaction value: $0
Shares: -21,854
Change %: -34%
Price: $0.000000
Shares after: 42,877
Date: 29 Dec 2022
Ownership: See Footnote
Footnotes: F13, F14

RPTX transaction

Common Shares

Other

Transaction value: $0
Shares: +4,721
Change %
Price: $0.000000
Shares after: 4,721
Date: 29 Dec 2022
Ownership: See Footnote
Footnotes: F15, F16

RPTX transaction

Common Shares

Other

Transaction value: $0
Shares: -4,721
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 29 Dec 2022
Ownership: See Footnote
Footnotes: F16, F17

RPTX transaction

Common Shares

Other

Transaction value: $0
Shares: +3,014
Change %: +14%
Price: $0.000000
Shares after: 25,131
Date: 29 Dec 2022
Ownership: Direct
Footnotes: F18

RPTX holding

Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,094,451
Date: 29 Dec 2022
Ownership: See Footnote
Footnotes: F19

RPTX holding

Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 231,211
Date: 29 Dec 2022
Ownership: See Footnote
Footnotes: F20

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 20 footnotes

Footnote F1

Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital V, L.P. ("VVC V") to its partners.

Footnote F2

Shares held by VVC V. Versant Ventures V, LLC ("VV V") is the sole general partner of VVC V. The Reporting Person, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VVC V. Each of VV V and the Reporting Person disclaims beneficial ownership of the shares held by VVC V, except to the extent of their respective pecuniary interests therein.

Footnote F3

Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VVC V.

Footnote F4

Shares held by VV V. The Reporting Person, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VV V; however, the Reporting Person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Footnote F5

Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Affiliates Fund V, L.P. ("VAF V") to its partners.

Footnote F6

Shares held by VAF V. VV V is the sole general partner of VAF V. The Reporting Person, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VAF V. Each of VV V and the Reporting Person disclaims beneficial ownership of the shares held by VAF V, except to the extent of their respective pecuniary interests therein.

Footnote F7

Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VAF V.

Footnote F8

Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ophthalmic Affiliates Fund I, L.P. ("VOAF I") to its partners.

Footnote F9

Shares held by VOAF I. VV V is the sole general partner of VOAF I. The Reporting Person, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VOAF I. Each of VV V and the Reporting Person disclaims beneficial ownership of the shares held by VOAF I, except to the extent of their respective pecuniary interests therein.

Footnote F10

Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VOAF I.

Footnote F11

Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV V, to its members.

Footnote F12

Represents a change in the form of ownership of the Reporting Person by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VV V.

Footnote F13

Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital V (Canada) LP ("VVC V (Canada)") to its partners.

Footnote F14

Shares held by VVC V (Canada). Versant Ventures V (Canada) GP-GP, Inc. ("VV V (Canada) GP") is the sole general partner of Versant Ventures V (Canada), L.P. ("VV V (Canada)") and VV V (Canada) is the sole general partner of VVC V (Canada). The Reporting Person, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VVC V (Canada). Each of VV V (Canada), VV V (Canada) GP and the Reporting Person disclaims beneficial ownership of the shares held by VVC V (Canada), except to the extent of their respective pecuniary interests therein.

Footnote F15

Represents a change in the form of ownership of VV V (Canada) by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VVC V (Canada).

Footnote F16

Shares held by VV V (Canada). VV V (Canada) GP is the sole general partner of VV V (Canada). The Reporting Person, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VV V (Canada). Each of VV V (Canada) GP and the Reporting Person disclaims beneficial ownership of the shares held by VV V (Canada), except to the extent of their respective pecuniary interests therein.

Footnote F17

Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV V (Canada), to its partners.

Footnote F18

Footnote F19

Shares held by Versant Venture Capital VI, L.P. ("VVC VI"). Versant Ventures VI GP-GP, LLC ("VV VI GP") is the sole general partner of Versant Ventures VI GP, L.P. ("VV VI") and VV VI is the sole general partner of VVC VI. The Reporting Person, a member of the Issuer's board of directors, is a managing director of VV VI GP and may be deemed to share voting and dispositive power over the shares held by VVC VI. Each of VV VI GP, VV VI and the Reporting Person disclaims beneficial ownership of the shares held by VVC VI, except to the extent of their respective pecuniary interests therein.

Footnote F20

Shares held by Versant Vantage I, L.P. ("VV I"). Versant Vantage I GP-GP, LLC ("VV I GP-GP") is the sole general partner of Versant Vantage I GP, L.P. ("VV I GP") and VV I GP is the sole general partner of VV I. The Reporting Person, a member of the Issuer's board of directors, is a managing director of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I. Each of VV I GP-GP, VV I GP and the Reporting Person disclaims beneficial ownership of the shares held by VV I, except to the extent of their respective pecuniary interests therein.